At the time of enrolment, patients had been on PGAs for 3.99±0.28 years (1–7 years). The topical PGAs used included bimatoprost (Lumigan RC, Allergan Markham, Ontario, Canada) (8 patients), ...
a Represents net earnings attributable to AbbVie Inc. Intangible asset impairment primarily reflects partial impairment charges related to the U.S. Imbruvica and CoolSculpting intangible assets ...
Diluted EPS of $2.39 on a GAAP Basis, a Decrease of 12.1 Percent; Adjusted Diluted EPS of $10.12, a Decrease of 8.9 Percent; These Results Include ...
a Represents net earnings attributable to AbbVie Inc. Intangible asset impairment primarily reflects partial impairment charges related to the U.S. Imbruvica and CoolSculpting intangible assets. The ...
Pre-Market: 4:16:55 a.m. EST ...
After hours: 7 February at 7:54:48 pm GMT-5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback